The impact of cross-reactive immunity on the emergence of SARS-CoV-2 variants by Thompson, RN, Southall, E, Daon, Y, Lovell-Read, FA, Iwami, S, Thompson, CP, Obolski, U

Serological analysis in humans in Malaysian Borneo suggests prior exposure to H5 avian influenza near migratory shorebird habitats by Klim, H, William, T, Mellors, J, Brady, C, Rajahram, GS, Chua, TH, Brazal Monzó, H, John, JL, da Costa, K, Jeffree, MS, Temperton, NJ, Tipton, T, Thompson, CP, Ahmed, K, Drakeley, CJ, Carroll, MW, Fornace, KM

Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2... by Wellens, J, Edmans, M, Obolski, U, McGregor, CGC, Simmonds, P, Turner, M, Jarvis, L, Skelly, D, Dunachie, S, Barnes, E, Eyre, DW, Colombel, J-F, Wong, S-Y, Klenerman, P, Lindsay, JO, Satsangi, J, Thompson, CP

Cellular immunity to SARS-CoV-2 following intrafamilial exposure in seronegative family members by Jay, C, Adland, E, Csala, A, Dold, C, Edmans, M, Hackstein, C-P, Jamsen, A, Lim, N, Longet, S, Ogbe, A, Sampson, O, Skelly, D, Spiller, OB, Stafford, L, Thompson, CP, Turtle, L, Barnes, E, Dunachie, S, Carroll, M, Klenerman, P, Conlon, C, Goulder, P, Jones, LC

Hypoxic and pharmacological activation of HIFs inhibits SARS-CoV-2 infection of lung epithelial cells by Wing, P, Keeley, TP, Zhuang, X, Lee, JY, Prange-Barczynska, M, Tsukuda, S, Morgan, SB, Harding, AC, Argles, ILA, Kurlekar, S, Noerenberg, M, Thompson, CP, Huang, K-YA, Balfe, P, Watashi, K, Castello, A, Hinks, TSC, James, W, Ratcliffe, PJ, Davis, I, Hodson, EJ, Bishop, T, McKeating, J

Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients by Youngs, J, Provine, NM, Lim, N, Sharpe, HR, Amini, A, Chen, Y-L, Luo, J, Edmans, MD, Zacharopoulou, P, Chen, W, Sampson, O, Paton, R, Hurt, WJ, Duncan, DA, McNaughton, AL, Miao, VN, Leaver, S, Wyncoll, DLA, Ball, J, Hopkins, P, Oxford Protective T cell Immunology for COVID-19 (OPTIC) Clinical team, Skelly, DT, Barnes, E, Dunachie, S, Ogg, G, Lambe, T, Pavord, I, Shalek, AK, Thompson, CP, Xue, L, Macallan, DC, Goulder, P, Klenerman, P, Bicanic, T

Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020 by Thompson, CP, Grayson, N, Paton, R, Bolton, JS, Lourenco, J, Penman, B, Lee, LN, Odon, V, Mongkolsapaya, J, Chinnakannan, S, Dejnirattisai, W, Edmans, M, Fyfe, A, Imlach, C, Kooblall, K, Lim, N, Liu, C, Lopez-Camacho, C, McInally, C-A, McNaughton, AL, Ramamurthy, N, Ratcliff, J, Supasa, P, Wang, B, Mentzer, AJ, Turner, M, Sampson, O, Semple, C, Baillie, JK, ISARIC4C Investigators, Harvala, H, Screaton, G, Temperton, N, Klenerman, P, Jarvis, L, Gupta, S, Simmonds, P

Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses by McNaughton, AL, Paton, RS, Edmans, M, Youngs, J, Wellens, J, Phalora, P, Fyfe, A, Belij-Rammerstorfer, S, Bolton, JS, Ball, J, Carnell, GW, Dejnirattisai, W, Dold, C, Eyre, DW, Hopkins, P, Howarth, A, Kooblall, K, Klim, H, Leaver, S, Lee, LN, López-Camacho, C, Lumley, SF, Macallan, DC, Mentzer, AJ, Provine, NM, Ratcliff, J, Slon-Compos, J, Skelly, D, Stolle, L, Supasa, P, Temperton, N, Walker, C, Wang, B, Wyncoll, D, Simmonds, P, Lambe, T, Baillie, JK, Semple, MG, Openshaw, PJM, Obolski, U, Turner, M, Carroll, M, Mongkolsapaya, J, Screaton, G, Kennedy, SH, Jarvis, L, Barnes, E, Dunachie, S, Lourenço, J, Matthews, PC, Bicanic, T, Klenerman, P, Gupta, S, Thompson, CP